Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial
Titel:
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial
Auteur:
Samson, S. L. Sathyanarayana, P. Jogi, M. Gonzalez, E. V. Gutierrez, A. Krishnamurthy, R. Muthupillai, R. Chan, L. Bajaj, M.